Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

AbbVie Projects Strong Single-Digit Growth Until 2030 - Chicago Today

10 Mar, 2026

Keytruda Retains Top Selling Status Amid Rising Popularity of GLP-1 Medications - BioSpace

04 Mar, 2026

Johnson & Johnson and AbbVie: A Competitive Growth Battle in the Face of Patent Expirations

23 Feb, 2026

Will Immunology Medications Keep Boosting AbbVie's Revenue in 2026? - TradingView

20 Feb, 2026

See More